Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
The current price of Merck & Co Inc in the market is ₺5.172,46, with a 24-hour trading volume of ₺17,52M. The asset's market cap is ₺12,77T, after moving 0.35% in the last day.
Tokenized Merck & Co Inc is trading at ₺5.215,95, with a tokenized market cap of ₺38,27M and a 24-hour trading volume of ₺45,21M. The tokenized asset has moved -2.62% in the past 24 hours.